HUSBAND & REZNEK´S IMAGING IN ONCOLOGY (HARDBACK). 4TH EDITION

• PART I: Primary Tumour Evaluation and Staging
1 Tumours of the oral cavity and pharynx
2 Paranasal sinus and nasal cavity neoplasms
3 Laryngeal tumours
4 Thyroid cancer
5 Mediastinal tumours
6 Lung cancer
7 Pleural tumours
8 Breast cancer
9 Esophageal cancer
10 Gastric cancer
11 Primary tumours of the liver and biliary tract
12 Pancreatic malignancy
13 Renal cancer
14 Primary adrenal malignancy
15 Primary retroperitoneal tumours
16 Bladder cancer
17 Prostate cancer
18 Testicular cancer
19 Ovarian cancer
20 Cervical and uterine tumors
21 Colorectal cancer
22 Primary bone tumours
23 Soft tissue sarcomas
24 Neuroendocrine tumours
• PART II: Haematological Malignancy and Immune Related Malignancy
25 Lymphoma
26 Multiple myeloma
• PART III: Metastases
27 Brain metastases
28 Lymph node metastases
29 Lung and pleural metastases
30 Bone metastases
31 Liver and spleen metastases
32 Adrenal metastases
33 Peritoneal metastases
• PART IV: Disease Response and Treatment
34 Assessment of response to treatment
35 Tumor specific disease response criteria
36 Immunotherapy response
• PART V: Effects on Normal Tissue and Complications of Treatments
37 Oncological effects on the Central Nervous System
38 Effects of treatment on the thorax
39 Effects of treatment on the abdomen and pelvis
40 Effects of treatment on bone and bone marrow
• PART VI: Functional and Molecular Imaging
41 PET CT: Principles and clinical applications
42 Functional imaging and emerging techniques in MRI
43 Functional imaging and emerging techniques in CT
44 Non FDG radionuclide imaging and targeted therapies

This comprehensive reference provides an overview of the general principles of cancer staging, as well as specific discussions of each tumour type across the body, including lymphoma and haematological malignancies. For each tumour, the pattern of disease involvement and disease spread are emphasized, the state-of-the-art imaging features surveyed, and the latest tumour staging and methods to assess treatment response are addressed. Separate sections discuss metastatic disease and the effects of treatment on normal and diseased tissues. The final section of the book highlights emerging functional and molecular imaging techniques to evaluate the different biological hallmarks of cancer.

Authors
• Anju Sahdev is the director of research for Clinical Support Services (CSS) and leads the Research Team within the Department of Imaging. Her many research achievements include multiple awards and prizes from a number of international and national organisations for her work involving MRI and endocrine/GU/gynaecological radiology including RSNA, UKRC, ECR and The British Medical Journal. She is also the reporting radiologist on MEDAL, METRO BIBF, METERO, ICON8, PANDA, PISARRO, LOGS, INTERLACE, ARIEL 3 and NEPTUNE. • Sarah Vinnicombe is a Clinical Senior Lecturer in Cancer Imaging and Consultant. Radiologist at Ninewells Hospital Medical School, University of Dundee. She was the British Society of Breast Radiologists' Visiting Professor in 2013 and has been elected Fellow of the International Cancer Imaging Society.